Home › Post-COVID Conditions (Long COVID) › Texas › League City
Post-COVID Conditions (Long COVID) clinical trials in League City, TX
3 studies for Post-COVID Conditions (Long COVID) are looking for participants at sites in and around League City (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Safety and Immunogenicity Trial of OCU500, ChAd36 Vector Encoding SARS-CoV-2 Spike Vaccine Via Intranasal and Inhalational Routes in Previously Vaccinated Adults
RecruitingPhase 1Healthy volunteers welcome
- University of Texas Medical Branch, Galveston · 23 mi away
Impact of COVID-19 Pandemic on Out-of-Pocket Costs, Lost Wages, and Unemployment in Patients With Breast Cancer Undergoing Breast Surgery
RecruitingObservational study
- MD Anderson League City, League City
Intervention to Prevent Behavioral Health Symptoms Among Pandemic Affected Children
RecruitingHealthy volunteers welcome
- Dickinson Independent School District, Dickinson · 4 mi away
- Communities in Schools of Galveston County, La Marque · 12 mi away
About Post-COVID Conditions (Long COVID)
Anyone who had COVID-19 can have ongoing symptoms. Learn about post-COVID conditions (long COVID), including symptoms, diagnosis, treatments, and prevention.
More about Post-COVID Conditions (Long COVID) on MedlinePlus
Post-COVID Conditions (Long COVID) trials in other cities
- New York City, NY15 studies
- Houston, TX13 studies
- Boston, MA13 studies
- Baltimore, MD12 studies
- Chicago, IL11 studies
- Washington, DC10 studies
- San Francisco, CA8 studies
- Durham, NC8 studies
- Atlanta, GA8 studies
- San Diego, CA7 studies
- Los Angeles, CA6 studies
- Pittsburgh, PA6 studies
Other studies in League City
- Non-Small Cell Lung Cancer15 studies
- Breast Cancer12 studies
- Metastatic Cancer7 studies
- Ulcerative Colitis6 studies
- Lung Cancer6 studies
- Colorectal Cancer6 studies
- Cancer (all types)5 studies
- Ovarian Cancer5 studies
- Stroke5 studies
- Bladder Cancer4 studies
- Head and Neck Squamous Cell Carcinoma4 studies
- Prostate Cancer4 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.